Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

43.76 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Feb 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Biosimilars Market 2023 Industry Size, Share, Growth and Analysis by Demand, Opportunity, Key Players, Regional Development and Forecast 2029
Biosimilars Market Size, Share and Forecast 2023-2029 Key Players are – Samsung Biologics, Intas Pharmaceuticals Ltd, Celltrion, Reliance Life Sciences, Pfizer, Coherus BioSciences, Amgen, Biocon Ltd 
Via SBWire
Topics Intellectual Property
Exposures Intellectual Property
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
Can gains in Tesla, Zoom, Exact Sciences, and other growth stocks set the stage for Cathie Woods' Ark Innovation Fund to stage a comeback in 2023? 
Via MarketBeat
Topics ETFs
Novavax Shares Jumped in January While Others Slipped
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line. 
Via MarketBeat
Exposures COVID-19 Product Safety
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Pfizer stock is bouncing up and down after mixed Q4 earnings. There's been an emotional battle between bulls and bears but it's time for both to get rational 
Via MarketBeat
Capturing the U.S. Health Care Space with XLV
Via Get News
Topics ETFs
Exposures COVID-19
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
From Pfizer Inc.
Via Business Wire
MarketBeat Week in Review – 1/23- 1/27
Markets were pushing hard to continue the rally as.recession fears and layoff announcements offset two data points that suggest inflation may be easing 
Via MarketBeat
Topics Economy Workforce
Exposures Economy Interest Rates Layoff
How Could GSK's RSV Vaccine Change its Valuation?
GSK's RSV vaccine could be a good earner for the company, according to outside analysts and its own predictions for the future. 
Via MarketBeat
Exposures Product Safety
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000. 
Via MarketBeat
A Comprehensive Study Exploring Balantidiasis Market : Key Players Fougera Pharmaceuticals, Medtronic, NuVasive
Get Balantidiasis Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis. 
Via SBWire
When Does Pfizer Become A Bargain?
With a price-to-earnings ratio of less than 9 and a dividend yield of 3.63% you have to be thinking that Pfizer may a bit of a bargain down here. 
Via MarketBeat
Exposures COVID-19
Tumor Lysis Syndrome Market Projected to Show Strong Growth : AbbVie, Hikma Pharmaceuticals, Amgen, Genentech
Get an extensive Tumor Lysis Syndrome Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna and Pfizer Race to Release RSV Vaccines
Two of the largest vaccine producers have engaged in the rapid development of RSV vaccines, here's how the companies are tracking so far. 
Via MarketBeat
Exposures Product Safety
AbbVie Stock: Dividend King ABBV Overview
Via MarketBeat
Drug Delivery Market – Major Technology Giants in Buzz Again : Johnson & Johnson, Sanofi, Pfizer
How to reach that market place and its associated audience with current marketing efforts? Benchmark now the competitive efforts with high growth emerging players and leaders of Drug Delivery Market. 
Via SBWire
Health and Beauty Products Market to Eyewitness Massive Growth by 2028 : Wallgreen, Coty, Nestle
Stay up-to-date with Health and Beauty Products Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries
From Pfizer Inc.
Via Business Wire
"CDC, FDA…link between Pfizer's shot & strokes" 2 years after FDA warning; Media Failing US: Expert
January 15, 2023 -- FDA's warning of death, strokes, and serious reactions from the shot posted at https://www.fda.gov/media/143557/download pg 16 Oct 22, 2020 were never reported by media, says... 
Via 24-7 Press Release
Exposures Product Safety
Direct to Consumer Pharmaceutical Advertising Market Is Going to Boom : Pfizer, Merck, GlaxoSmithKline
Stay up-to-date with Direct To Consumer Pharmaceutical Advertising Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Atypical Digital, A Global Digital Marketing Tech Enabled Company, acquires South Korea-based Springworks
Via AB Newswire
Four Undervalued Healthcare Stocks for 2023
These four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc. 
Via MarketBeat
Exposures COVID-19
A Comprehensive Study Exploring Nephroblastoma Treatment Market: Key Players Bayer HealthCare, Pfizer, AstraZeneca
Get an extensive Nephroblastoma Treatment Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children
From Pfizer Inc.
Via Business Wire
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
The Year of the Tripledemic
COVID-19 may have lost its daily news headline status, but the disease rages on with 2700 weekly deaths in the U.S. and millions of Americans chronically disabled from long-COVID, 4 million of which... 
Via TheNewswire.com
Topics Death
Exposures COVID-19 Death Product Safety
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate
From Pfizer Inc.
Via Business Wire
Big Health Care Stocks to Watch in the New Year
Here are three health care stocks to watch as the New Year begins. Two have a moderate Buy rating while one is a Hold, for now. 
Via MarketBeat
DeepThink Health Appoints Krish Ghosh as Executive Vice President and General Manager, Life Sciences
Ghosh Brings Three Decades of Life Sciences Experience to DeepThink HealthSAN RAMON, Calif. - Dec. 28, 2022 - PRLog -- DeepThink Health, Inc., an AI-powered leader in the transformation of health data... 
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.